SIX:PPGN
PolyPeptide Group AG
- Stock
Last Close
28.20
26/07 15:30
Market Cap
483.30M
Beta: 0.92
Volume Today
10.95K
Avg: 91.45K
PE Ratio
69.04
PFCF: −7.30
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 72.91M - | 83.88M 15.04% | 103.64M 23.55% | 129.04M 24.51% | 136.79M 6.01% | ||
average payables | 16.60M - | 23.41M 41.06% | 28.42M 21.40% | 37.21M 30.92% | 53.42M 43.57% | ||
average receivables | 33.83M - | 74.17M 119.22% | 74.04M 0.17% | 75.11M 1.44% | |||
book value per share | 4.92 - | 4.98 1.18% | 5.92 18.90% | 13.12 121.58% | 12.78 2.58% | 11.56 9.54% | |
capex per share | -0.61 - | -0.66 7.69% | -1.44 119.24% | -2.42 68.12% | -2.39 1.37% | -1.72 27.93% | |
capex to depreciation | -1.27 - | -1.25 1.75% | -2.46 97.53% | -3.76 52.58% | -3.02 19.56% | -1.86 38.39% | |
capex to operating cash flow | -0.80 - | -0.35 55.56% | -0.87 145.07% | -1.35 56.00% | -14.43 964.68% | -1.55 89.22% | |
capex to revenue | -0.10 - | -0.10 4.56% | -0.19 99.17% | -0.28 42.20% | -0.28 1.77% | -0.18 36.83% | |
cash per share | 0.33 - | 0.58 74.43% | 0.57 1.71% | 4.25 640.34% | 1.14 73.21% | 2.90 155.16% | |
days of inventory on hand | 224.79 - | 204.70 8.94% | 227.71 11.24% | 226.09 0.71% | 231.24 2.28% | 148.56 35.76% | |
days payables outstanding | 45.78 - | 51.42 12.32% | 68.50 33.22% | 56.99 16.81% | 73.22 28.48% | 70.41 3.83% | |
days sales outstanding | 110.74 - | 104.37 5.75% | 87.57 16.09% | 115.15 31.49% | |||
debt to assets | 0.15 - | 0.12 23.98% | 0.10 14.08% | 0.03 69.61% | 0.04 21.79% | 0.16 347.60% | |
debt to equity | 0.29 - | 0.24 19.22% | 0.21 10.97% | 0.04 79.71% | 0.05 17.70% | 0.30 492.53% | |
dividend yield | 0.00 - | 0.01 224.00% | |||||
earnings yield | 0.01 - | 0.01 4.28% | 0.02 20.96% | 0.01 38.34% | 0.01 17.48% | -0.08 1,001.22% | |
enterprise value | 1.70B - | 1.74B 2.64% | 1.76B 0.78% | 4.13B 135.06% | 829.87M 79.91% | 639.80M 22.90% | |
enterprise value over ebitda | 39.89 - | 35.29 11.52% | 29.85 15.43% | 49.55 66.03% | 23.23 53.12% | -28.88 224.33% | |
ev to operating cash flow | 74.04 - | 31.36 57.65% | 35.33 12.65% | 72.02 103.86% | 151.99 111.05% | 17.54 88.46% | |
ev to sales | 9.46 - | 8.61 9.03% | 7.88 8.45% | 14.64 85.83% | 2.95 79.83% | 2.00 32.38% | |
free cash flow per share | 0.15 - | 1.20 672.77% | 0.22 81.78% | -0.63 390.96% | -2.22 250.40% | -0.61 72.36% | |
free cash flow yield | 0.00 - | 0.02 645.80% | 0.00 81.90% | -0.00 227.26% | -0.09 1,708.09% | -0.03 62.41% | |
graham net net | -3.00 - | -3.38 12.81% | -2.77 17.99% | 2.48 189.22% | 0.20 92.01% | -2.19 1,206.41% | |
graham number | 9.38 - | 9.80 4.56% | 11.80 20.32% | 20.85 76.73% | 8.23 60.53% | 20.15 144.83% | |
income quality | 0.96 - | 2.16 124.29% | 1.59 26.52% | 1.21 23.55% | 0.70 42.07% | -0.71 200.90% | |
intangibles to total assets | 0.04 - | 0.04 4.97% | 0.03 17.23% | 0.02 28.20% | 0.03 14.91% | 0.02 13.34% | |
interest coverage | 6.74 - | 10.35 53.42% | 13.39 29.41% | 22.73 69.79% | 4.62 79.68% | -6.49 240.41% | |
interest debt per share | 1.58 - | 1.29 18.53% | 1.36 5.56% | 0.65 52.23% | 0.71 8.90% | 3.62 412.03% | |
inventory turnover | 1.62 - | 1.78 9.82% | 1.60 10.10% | 1.61 0.71% | 1.58 2.23% | 2.46 55.66% | |
invested capital | 0.29 - | 0.24 19.22% | 0.21 10.97% | 0.04 79.71% | 0.05 17.70% | 0.30 492.53% | |
market cap | 1.67B - | 1.73B 3.62% | 1.74B 0.65% | 4.25B 144.61% | 846.18M 80.08% | 621.84M 26.51% | |
net current asset value | 5.10M - | -13.06M 356.12% | -18.45M 41.33% | 157.74M 954.83% | 97.47M 38.21% | 18.74M 80.77% | |
net debt to ebitda | 0.78 - | 0.36 53.69% | 0.34 4.93% | -1.42 513.13% | -0.46 67.83% | -0.81 77.54% | |
net income per share | 0.79 - | 0.86 8.05% | 1.04 21.75% | 1.47 40.96% | 0.24 84.01% | -1.56 762.65% | |
operating cash flow per share | 0.76 - | 1.85 142.34% | 1.66 10.54% | 1.79 7.77% | 0.17 90.74% | 1.11 568.59% | |
payables turnover | 7.97 - | 7.10 10.97% | 5.33 24.94% | 6.41 20.21% | 4.99 22.17% | 5.18 3.98% | |
receivables turnover | 3.30 - | 3.50 6.10% | 4.17 19.18% | 3.17 23.95% | |||
research and ddevelopement to revenue | 0.07 - | 0.07 3.52% | 0.01 91.71% | 0.00 15.22% | 0.00 11.30% | 0.00 3.37% | |
return on tangible assets | 0.09 - | 0.09 0.70% | 0.09 1.90% | 0.08 5.63% | 0.01 82.95% | -0.08 651.31% | |
revenue per share | 5.99 - | 6.75 12.83% | 7.43 10.08% | 8.79 18.23% | 8.52 3.09% | 9.72 14.08% | |
roe | 0.16 - | 0.17 6.79% | 0.18 2.40% | 0.11 36.38% | 0.02 83.58% | -0.13 832.57% | |
roic | 0.12 - | 0.15 24.48% | 0.16 10.81% | 0.11 31.67% | 0.02 80.73% | -0.06 390.99% | |
sales general and administrative to revenue | 0.05 - | 0.04 7.35% | 0.05 4.15% | 0.05 5.53% | 0.06 22.54% | 0.05 11.04% | |
shareholders equity per share | 4.92 - | 4.98 1.18% | 5.92 18.90% | 13.12 121.58% | 12.78 2.58% | 11.56 9.54% | |
stock based compensation to revenue | 0.00 - | 0.00 4.00% | 0.00 36.06% | ||||
tangible asset value | 136.76M - | 137.10M 0.25% | 165.10M 20.42% | 406.90M 146.45% | 405.81M 0.27% | 364.77M 10.11% | |
tangible book value per share | 4.56 - | 4.57 0.25% | 5.50 20.42% | 12.68 130.35% | 12.30 2.96% | 11.06 10.06% | |
working capital | 77.31M - | 86.37M 11.72% | 78.01M 9.67% | 227.65M 191.80% | 155.52M 31.68% | 150.15M 3.45% |
All numbers in CHF (except ratios and percentages)